Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Sensitivity to S-Cone Stimuli and the Development of Myopia.

Taylor CP, Shepard TG, Rucker FJ, Eskew RT Jr.

Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4622-4630. doi: 10.1167/iovs.18-24113.

2.

Individual differences in responsivity to social rewards: Insights from two eye-tracking tasks.

Chakrabarti B, Haffey A, Canzano L, Taylor CP, McSorley E.

PLoS One. 2017 Oct 18;12(10):e0185146. doi: 10.1371/journal.pone.0185146. eCollection 2017.

3.

Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use.

Taylor CP, Traynelis SF, Siffert J, Pope LE, Matsumoto RR.

Pharmacol Ther. 2016 Aug;164:170-82. doi: 10.1016/j.pharmthera.2016.04.010. Epub 2016 Apr 29. Review.

4.

On the number of perceivable blur levels in naturalistic images.

Taylor CP, Bex PJ.

Vision Res. 2015 Oct;115(Pt A):142-50. doi: 10.1016/j.visres.2014.12.025. Epub 2015 Mar 2.

5.

Evidence for adjustable bandwidth orientation channels.

Taylor CP, Bennett PJ, Sekuler AB.

Front Psychol. 2014 Jun 12;5:578. doi: 10.3389/fpsyg.2014.00578. eCollection 2014.

6.

Effect of brimonidine on retinal vascular autoregulation and short-term visual function in normal tension glaucoma.

Feke GT, Bex PJ, Taylor CP, Rhee DJ, Turalba AV, Chen TC, Wand M, Pasquale LR.

Am J Ophthalmol. 2014 Jul;158(1):105-112.e1. doi: 10.1016/j.ajo.2014.03.015. Epub 2014 Apr 5.

7.

Characterization of field loss based on microperimetry is predictive of face recognition difficulties.

Wallis TS, Taylor CP, Wallis J, Jackson ML, Bex PJ.

Invest Ophthalmol Vis Sci. 2014 Jan 7;55(1):142-53. doi: 10.1167/iovs.13-12420.

8.

The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?

Stahl SM, Porreca F, Taylor CP, Cheung R, Thorpe AJ, Clair A.

Trends Pharmacol Sci. 2013 Jun;34(6):332-9. doi: 10.1016/j.tips.2013.04.001. Epub 2013 May 2. Review.

PMID:
23642658
9.

Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits.

Li Z, Taylor CP, Weber M, Piechan J, Prior F, Bian F, Cui M, Hoffman D, Donevan S.

Eur J Pharmacol. 2011 Sep 30;667(1-3):80-90. doi: 10.1016/j.ejphar.2011.05.054. Epub 2011 Jun 1.

PMID:
21651903
10.

Anxiolytic-like activity of pregabalin in the Vogel conflict test in α2δ-1 (R217A) and α2δ-2 (R279A) mouse mutants.

Lotarski SM, Donevan S, El-Kattan A, Osgood S, Poe J, Taylor CP, Offord J.

J Pharmacol Exp Ther. 2011 Aug;338(2):615-21. doi: 10.1124/jpet.111.180976. Epub 2011 May 10.

PMID:
21558437
11.

The effect of aging on the spatial frequency selectivity of the human visual system.

Govenlock SW, Taylor CP, Sekuler AB, Bennett PJ.

Vision Res. 2010 Aug 6;50(17):1712-9. doi: 10.1016/j.visres.2010.05.025. Epub 2010 May 25.

12.

Central sensitization and Ca(V)α₂δ ligands in chronic pain syndromes: pathologic processes and pharmacologic effect.

Tuchman M, Barrett JA, Donevan S, Hedberg TG, Taylor CP.

J Pain. 2010 Dec;11(12):1241-9. doi: 10.1016/j.jpain.2010.02.024. Epub 2010 May 15. Review.

PMID:
20472509
13.

Spatial frequency summation in visual noise.

Taylor CP, Bennett PJ, Sekuler AB.

J Opt Soc Am A Opt Image Sci Vis. 2009 Nov;26(11):B84-93. doi: 10.1364/JOSAA.26.000B84.

PMID:
19884918
14.

Mechanisms of analgesia by gabapentin and pregabalin--calcium channel alpha2-delta [Cavalpha2-delta] ligands.

Taylor CP.

Pain. 2009 Mar;142(1-2):13-6. doi: 10.1016/j.pain.2008.11.019. Epub 2009 Jan 6. Review. No abstract available.

PMID:
19128880
15.

Oxadiazolone bioisosteres of pregabalin and gabapentin.

Wustrow DJ, Belliotti TR, Capiris T, Kneen CO, Bryans JS, Field MJ, Williams D, El-Kattan A, Buchholz L, Kinsora JJ, Lotarski SM, Vartanian MG, Taylor CP, Donevan SD, Thorpe AJ, Schwarz JB.

Bioorg Med Chem Lett. 2009 Jan 1;19(1):247-50. doi: 10.1016/j.bmcl.2008.10.101. Epub 2008 Oct 25.

PMID:
19010672
16.

The effect of aging on the orientational selectivity of the human visual system.

Govenlock SW, Taylor CP, Sekuler AB, Bennett PJ.

Vision Res. 2009 Jan;49(1):164-72. doi: 10.1016/j.visres.2008.10.004. Epub 2008 Nov 22.

17.

Anxiolytic profile of pregabalin on elicited hippocampal theta oscillation.

Siok CJ, Taylor CP, Hajós M.

Neuropharmacology. 2009 Feb;56(2):379-85. doi: 10.1016/j.neuropharm.2008.09.013. Epub 2008 Oct 7.

PMID:
18930748
18.

Immunostaining of rat brain, spinal cord, sensory neurons and skeletal muscle for calcium channel alpha2-delta (alpha2-delta) type 1 protein.

Taylor CP, Garrido R.

Neuroscience. 2008 Aug 13;155(2):510-21. doi: 10.1016/j.neuroscience.2008.05.053. Epub 2008 Jun 14.

PMID:
18616987
19.

Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A.

Taylor CP, Tummala S, Molrine D, Davidson L, Farrell RJ, Lembo A, Hibberd PL, Lowy I, Kelly CP.

Vaccine. 2008 Jun 25;26(27-28):3404-9. doi: 10.1016/j.vaccine.2008.04.042. Epub 2008 May 7.

20.

Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease.

Katchar K, Taylor CP, Tummala S, Chen X, Sheikh J, Kelly CP.

Clin Gastroenterol Hepatol. 2007 Jun;5(6):707-13.

PMID:
17544998
21.

Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission.

Dooley DJ, Taylor CP, Donevan S, Feltner D.

Trends Pharmacol Sci. 2007 Feb;28(2):75-82. Epub 2007 Jan 10. Review. Erratum in: Trends Pharmacol Sci. 2007 Apr;28(4):151.

PMID:
17222465
22.
23.
24.

Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.

Micheva KD, Taylor CP, Smith SJ.

Mol Pharmacol. 2006 Aug;70(2):467-76. Epub 2006 Apr 26.

PMID:
16641316
25.

Carboxylate bioisosteres of pregabalin.

Schwarz JB, Colbry NL, Zhu Z, Nichelson B, Barta NS, Lin K, Hudack RA, Gibbons SE, Galatsis P, DeOrazio RJ, Manning DD, Vartanian MG, Kinsora JJ, Lotarski SM, Li Z, Dickerson MR, El-Kattan A, Thorpe AJ, Donevan SD, Taylor CP, Wustrow DJ.

Bioorg Med Chem Lett. 2006 Jul 1;16(13):3559-63. Epub 2006 Apr 18.

PMID:
16621528
26.
27.

Activity profile of pregabalin in rodent models of epilepsy and ataxia.

Vartanian MG, Radulovic LL, Kinsora JJ, Serpa KA, Vergnes M, Bertram E, Taylor CP.

Epilepsy Res. 2006 Mar;68(3):189-205. Epub 2005 Dec 5.

PMID:
16337109
28.

The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases.

Hu LY, Boxer PA, Kesten SR, Lei HJ, Wustrow DJ, Moreland DW, Zhang L, Ahn K, Ryder TR, Liu X, Rubin JR, Fahnoe K, Carroll RT, Dutta S, Fahnoe DC, Probert AW, Roof RL, Rafferty MF, Kostlan CR, Scholten JD, Hood M, Ren XD, Schielke GP, Su TZ, Taylor CP, Mistry A, McConnell P, Hasemann C, Ohren J.

Bioorg Med Chem Lett. 2006 May 1;16(9):2337-40. Epub 2005 Sep 6.

PMID:
16143519
29.

Carboxylate bioisosteres of gabapentin.

Burgos-Lepley CE, Thompson LR, Kneen CO, Osborne SA, Bryans JS, Capiris T, Suman-Chauhan N, Dooley DJ, Donovan CM, Field MJ, Vartanian MG, Kinsora JJ, Lotarski SM, El-Kattan A, Walters K, Cherukury M, Taylor CP, Wustrow DJ, Schwarz JB.

Bioorg Med Chem Lett. 2006 May 1;16(9):2333-6. Epub 2005 Jun 8.

PMID:
15946842
30.

Genetically engineered probiotics: a new twist on an old remedy.

Taylor CP, LaMont JT.

Gastroenterology. 2005 May;128(5):1509-12. Review. No abstract available.

PMID:
15887131
31.

Novel cyclopropyl beta-amino acid analogues of pregabalin and gabapentin that target the alpha2-delta protein.

Schwarz JB, Gibbons SE, Graham SR, Colbry NL, Guzzo PR, Le VD, Vartanian MG, Kinsora JJ, Lotarski SM, Li Z, Dickerson MR, Su TZ, Weber ML, El-Kattan A, Thorpe AJ, Donevan SD, Taylor CP, Wustrow DJ.

J Med Chem. 2005 Apr 21;48(8):3026-35.

PMID:
15828841
32.

Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein.

Belliotti TR, Capiris T, Ekhato IV, Kinsora JJ, Field MJ, Heffner TG, Meltzer LT, Schwarz JB, Taylor CP, Thorpe AJ, Vartanian MG, Wise LD, Zhi-Su T, Weber ML, Wustrow DJ.

J Med Chem. 2005 Apr 7;48(7):2294-307.

PMID:
15801823
33.

Aging reduces center-surround antagonism in visual motion processing.

Betts LR, Taylor CP, Sekuler AB, Bennett PJ.

Neuron. 2005 Feb 3;45(3):361-6.

34.

Syntheses in enantiopure form of four diastereoisomeric naphthopyranquinones derived from aphid insect pigments.

Aggarwal R, Giles RG, Green IR, Oosthuizen FJ, Taylor CP.

Org Biomol Chem. 2005 Jan 21;3(2):263-73. Epub 2004 Dec 2.

PMID:
15632968
37.

Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia.

Hurley RW, Chatterjea D, Rose Feng M, Taylor CP, Hammond DL.

Anesthesiology. 2002 Nov;97(5):1263-73.

PMID:
12411814
38.

MRSA pyomyositis complicating sickle cell anaemia.

Millar C, Page T, Paterson P, Taylor CP.

Clin Lab Haematol. 2001 Oct;23(5):329-32.

PMID:
11703417
39.

ALS defeats gabapentin: reflections on another failed treatment.

Brigell MG, Taylor CP.

Neurology. 2001 Oct 23;57(8):1524-5. No abstract available.

PMID:
11673613
41.

Effects of ion channel blockade on the distribution of Na, K, Ca and other elements in oxygen-glucose deprived CA1 hippocampal neurons.

LoPachin RM, Gaughan CL, Lehning EJ, Weber ML, Taylor CP.

Neuroscience. 2001;103(4):971-83.

PMID:
11301205
42.

Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin.

Hulsebosch CE, Xu GY, Perez-Polo JR, Westlund KN, Taylor CP, McAdoo DJ.

J Neurotrauma. 2000 Dec;17(12):1205-17.

PMID:
11186233
43.
44.

Neuronal N-type calcium channel blockers: a series of 4-piperidinylaniline analogs with analgesic activity.

Hu LY, Ryder TR, Rafferty MF, Siebers KM, Malone T, Chatterjee A, Feng MR, Lotarski SM, Rock DM, Stoehr SJ, Taylor CP, Weber ML, Miljanich GP, Millerman E, Szoke BG.

Drug Des Discov. 2000;17(1):85-93.

PMID:
10928451
45.

The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phen yl]-(3-methyl-but-2-enyl)-amine, an N-type Ca+2 channel blocker with oral activity for analgesia.

Hu LY, Ryder TR, Rafferty MF, Taylor CP, Feng MR, Kuo BS, Lotarski SM, Miljanich GP, Millerman E, Siebers KM, Szoke BG.

Bioorg Med Chem. 2000 Jun;8(6):1203-12.

PMID:
10896101
46.
47.

Structure-activity relationship at the leucine side chain in a series of N,N-dialkyldipeptidyl-amines as N-type calcium channel blockers.

Ryder TR, Hu LY, Rafferty MF, Lotarski SM, Rock DM, Stoehr SJ, Taylor CP, Weber ML, Miljanich GP, Millerman E, Szoke BG.

Drug Des Discov. 2000;16(4):317-22.

PMID:
10807036
48.

Mechanisms of new antiepileptic drugs.

Taylor CP.

Adv Neurol. 1999;79:1011-26. Review. No abstract available.

PMID:
10514883
49.

Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic properties.

Hu LY, Ryder TR, Rafferty MF, Feng MR, Lotarski SM, Rock DM, Sinz M, Stoehr SJ, Taylor CP, Weber ML, Bowersox SS, Miljanich GP, Millerman E, Wang YX, Szoke BG.

J Med Chem. 1999 Oct 7;42(20):4239-49.

PMID:
10514294
50.

Structure-activity relationship at the proximal phenyl group in a series of non-peptidyl N-type calcium channel antagonists.

Ryder TR, Hu LY, Rafferty MF, Lotarski SM, Rock DM, Stoehr SJ, Taylor CP, Weber ML, Miljanich GP, Millerman E, Szoke BG.

Bioorg Med Chem Lett. 1999 Aug 16;9(16):2453-8.

PMID:
10476886

Supplemental Content

Loading ...
Support Center